# REDITREX
> **NDA210737** · New Drug Application · Sponsor: NORDIC GRP · Approved 2019-11-27
## Drug
- **FDA Application Number:** NDA210737
- **Application type:** New Drug Application
- **Brand name:** REDITREX
- **Generic name:** Methotrexate
- **Active ingredients:** METHOTREXATE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** NORDIC GRP
- **First approval:** 2019-11-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210737)
---
*AI Analytics · CC0 1.0*